N-alkyltriazole compounds as LPAR antagonists
US9321738B2 · kind B2 · utility
4Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2013 |
| Grant date | Apr 26, 2016 |
| Priority date | — |
| Expiry date | Jun 23, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D249/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such as, for example, pulmonary fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.